Wall Street Zen cut shares of Novanta (NASDAQ:NOVT – Free Report) from a buy rating to a hold rating in a report released on Monday.
Novanta Stock Up 3.0%
Shares of NOVT opened at $124.87 on Monday. The company has a current ratio of 2.54, a quick ratio of 1.62 and a debt-to-equity ratio of 0.57. The stock’s 50 day moving average is $125.15 and its two-hundred day moving average is $128.57. The firm has a market cap of $4.49 billion, a P/E ratio of 73.45 and a beta of 1.48. Novanta has a 12 month low of $98.76 and a 12 month high of $186.75.
Novanta (NASDAQ:NOVT – Get Free Report) last issued its quarterly earnings results on Tuesday, August 5th. The technology company reported $0.76 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.74 by $0.02. The firm had revenue of $241.05 million for the quarter, compared to analyst estimates of $237.97 million. Novanta had a return on equity of 14.70% and a net margin of 6.41%. The business’s revenue was up 2.2% on a year-over-year basis. During the same period in the previous year, the company posted $0.73 earnings per share. Analysts predict that Novanta will post 3.03 earnings per share for the current fiscal year.
Institutional Trading of Novanta
Novanta Company Profile
Novanta, Inc engages in the provision of core technology solutions to healthcare and advanced industrial original equipment manufacturers. It operates through the following segments: Photonics, Vision, and Precision Motion. The Photonics segment designs, manufactures, and markets photonics-based solutions, including laser scanning and laser beam delivery, CO2 laser, continuous wave and ultrafast laser, and optical light engine products.
Featured Articles
- Five stocks we like better than Novanta
- Utilities Stocks Explained – How and Why to Invest in Utilities
- 3 Earnings Reports Give a Snapshot of Consumer Sentiment
- Are Penny Stocks a Good Fit for Your Portfolio?
- Amazon’s Bears Have Raised the White Flag—Get Excited
- How to Most Effectively Use the MarketBeat Earnings Screener
- Tempus AI’s Strong Q2 Fuels Growth Story—More Upside Ahead?
Receive News & Ratings for Novanta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novanta and related companies with MarketBeat.com's FREE daily email newsletter.